cmd condition onset (.xlsx) =========================== :download:`Download original .xlsx file from GitHub ` .. contents:: info ---- ==== ============================================================================================================================================================================================================================ .. ResourceFile\_cmd\_condition\_onset ==== ============================================================================================================================================================================================================================ 0 Created by Britta Jewell on 25 March 2021 1 2 This file reads in parameters for the onset of each condition annually in the CMD module in the TLO model. Each tab represents one condition modelled. 3 baseline\_annual\_probability has been calibrated for each condition to data from Malawi. All other parameters are from Professor Ed Gregg's group. Where possible, sources are listed to the right of the parameter values. ==== ============================================================================================================================================================================================================================ diabetes -------- ==== ===================================================== ================== ======================================= .. parameter\_name value Unnamed: 2 ==== ===================================================== ================== ======================================= 0 baseline\_annual\_probability 0.00028 1 rr\_male 1.15 Holden et al., 2013, UK Pop (CPRD) 2 rr\_0\_4 0 Holden et al., 2013, UK Pop (CPRD) 3 rr\_5\_9 0 Holden et al., 2013, UK Pop (CPRD) 4 rr\_10\_14 0 Holden et al., 2013, UK Pop (CPRD) 5 rr\_15\_19 0 Holden et al., 2013, UK Pop (CPRD) 6 rr\_20\_24 1 Holden et al., 2013, UK Pop (CPRD) 7 rr\_25\_29 1 Holden et al., 2013, UK Pop (CPRD) 8 rr\_30\_34 1.6 Holden et al., 2013, UK Pop (CPRD) 9 rr\_35\_39 2.215384615384615 Holden et al., 2013, UK Pop (CPRD) 10 rr\_40\_44 3 Holden et al., 2013, UK Pop (CPRD) 11 rr\_45\_49 4 Holden et al., 2013, UK Pop (CPRD) 12 rr\_50\_54 4.5 Holden et al., 2013, UK Pop (CPRD) 13 rr\_55\_59 6 Holden et al., 2013, UK Pop (CPRD) 14 rr\_60\_64 6.5 Holden et al., 2013, UK Pop (CPRD) 15 rr\_65\_69 7 Holden et al., 2013, UK Pop (CPRD) 16 rr\_70\_74 4 Holden et al., 2013, UK Pop (CPRD) 17 rr\_75\_79 3 Holden et al., 2013, UK Pop (CPRD) 18 rr\_80\_84 2 Holden et al., 2013, UK Pop (CPRD) 19 rr\_85\_89 2 Holden et al., 2013, UK Pop (CPRD) 20 rr\_90\_94 1 Holden et al., 2013, UK Pop (CPRD) 21 rr\_95\_99 1 Holden et al., 2013, UK Pop (CPRD) 22 rr\_100 1 Holden et al., 2013, UK Pop (CPRD) 23 rr\_urban 24 rr\_wealth\_1 1 Bellou et al., Systematic Reviews, 2018 25 rr\_wealth\_2 0.8333333333333334 Bellou et al., Systematic Reviews, 2018 26 rr\_wealth\_3 0.7916666666666666 Bellou et al., Systematic Reviews, 2018 27 rr\_wealth\_4 0.75 Bellou et al., Systematic Reviews, 2018 28 rr\_wealth\_5 0.7083333333333334 Bellou et al., Systematic Reviews, 2018 29 rr\_bmi\_1 1.1 Bellou et al., Systematic Reviews, 2018 30 rr\_bmi\_2 1 Bellou et al., Systematic Reviews, 2018 31 rr\_bmi\_3 2.9 Bellou et al., Systematic Reviews, 2018 32 rr\_bmi\_4 6 Bellou et al., Systematic Reviews, 2018 33 rr\_bmi\_5 10 Bellou et al., Systematic Reviews, 2018 34 rr\_low\_exercise 1.33 Bellou et al., Systematic Reviews, 2018 35 rr\_high\_salt 1 36 rr\_high\_sugar 1.2 Bellou et al., Systematic Reviews, 2018 37 rr\_tobacco 1.3 Bellou et al., Systematic Reviews, 2018 38 rr\_alcohol 39 rr\_marital\_status\_1 40 rr\_marital\_status\_2 41 rr\_marital\_status\_3 42 rr\_in\_education 1.2 Bellou et al., Systematic Reviews, 2018 43 rr\_current\_education\_level\_1 1.2 Bellou et al., Systematic Reviews, 2018 44 rr\_current\_education\_level\_2 1 Bellou et al., Systematic Reviews, 2018 45 rr\_current\_education\_level\_3 0.85 Bellou et al., Systematic Reviews, 2018 46 rr\_unimproved\_sanitation 1 47 rr\_no\_access\_handwashing 1 48 rr\_no\_clean\_drinking\_water 1.05 Estimates from Ed Gregg 49 rr\_wood\_burning\_stove 1.05 Estimates from Ed Gregg 50 rr\_diabetes 1 51 rr\_hypertension 1.75 Bellou et al., Systematic Reviews, 2018 52 rr\_depression 1.48 Bellou et al., Systematic Reviews, 2018 53 rr\_chronic\_kidney\_disease 1 54 rr\_chronic\_lower\_back\_pain 1 55 rr\_chronic\_ischemic\_heart\_disease 1 56 rr\_cancers 1 57 rr\_hiv 1 58 rr\_ever\_stroke 1 59 rr\_ever\_heart\_attack 1 60 rr\_diabetes\_on\_medication 1 61 rr\_hypertension\_on\_medication 1 62 rr\_chronic\_kidney\_disease\_on\_medication 1 63 rr\_chronic\_lower\_back\_pain\_on\_medication 1 64 rr\_chronic\_ischemic\_heart\_disease\_on\_medication 1 65 rr\_stroke\_on\_medication 1 66 rr\_heart\_attack\_on\_medication 1 ==== ===================================================== ================== ======================================= hypertension ------------ ==== ===================================================== =================== =========================================================== .. parameter\_name value Unnamed: 2 ==== ===================================================== =================== =========================================================== 0 baseline\_annual\_probability 0.0045 1 rr\_male 0.95 2 rr\_0\_4 0 Health Survey for England Hypertension Prevalence Models 3 rr\_5\_9 0 Health Survey for England Hypertension Prevalence Models 4 rr\_10\_14 0 Health Survey for England Hypertension Prevalence Models 5 rr\_15\_19 0 Health Survey for England Hypertension Prevalence Models 6 rr\_20\_24 0.33783783783783783 Health Survey for England Hypertension Prevalence Models 7 rr\_25\_29 1.0033783783783785 Health Survey for England Hypertension Prevalence Models 8 rr\_30\_34 1.0033783783783785 Health Survey for England Hypertension Prevalence Models 9 rr\_35\_39 1 Health Survey for England Hypertension Prevalence Models 10 rr\_40\_44 1 Health Survey for England Hypertension Prevalence Models 11 rr\_45\_49 1.652027027027027 Health Survey for England Hypertension Prevalence Models 12 rr\_50\_54 1.652027027027027 Health Survey for England Hypertension Prevalence Models 13 rr\_55\_59 2.135135135135135 Health Survey for England Hypertension Prevalence Models 14 rr\_60\_64 2.135135135135135 Health Survey for England Hypertension Prevalence Models 15 rr\_65\_69 2.385135135135135 Health Survey for England Hypertension Prevalence Models 16 rr\_70\_74 2.385135135135135 Health Survey for England Hypertension Prevalence Models 17 rr\_75\_79 2.679054054054054 Health Survey for England Hypertension Prevalence Models 18 rr\_80\_84 2.679054054054054 Health Survey for England Hypertension Prevalence Models 19 rr\_85\_89 2.679054054054054 Health Survey for England Hypertension Prevalence Models 20 rr\_90\_94 2.679054054054054 Health Survey for England Hypertension Prevalence Models 21 rr\_95\_99 2.679054054054054 Health Survey for England Hypertension Prevalence Models 22 rr\_100 2.679054054054054 Health Survey for England Hypertension Prevalence Models 23 rr\_urban 24 rr\_wealth\_1 1 Coyle et al., 2019, English GP Data 25 rr\_wealth\_2 1.0396039603960396 Coyle et al., 2019, English GP Data 26 rr\_wealth\_3 1.0693069306930694 Coyle et al., 2019, English GP Data 27 rr\_wealth\_4 1.0396039603960396 Coyle et al., 2019, English GP Data 28 rr\_wealth\_5 0.9900990099009901 Coyle et al., 2019, English GP Data 29 rr\_bmi\_1 0.5263157894736842 Health Survey for England Hypertension Prevalence Models 30 rr\_bmi\_2 1 Health Survey for England Hypertension Prevalence Models 31 rr\_bmi\_3 1.6894736842105265 Health Survey for England Hypertension Prevalence Models 32 rr\_bmi\_4 1.7210526315789474 Health Survey for England Hypertension Prevalence Models 33 rr\_bmi\_5 2.2052631578947373 Health Survey for England Hypertension Prevalence Models 34 rr\_low\_exercise 1.16 Andriolo et al., 2019, EPIC-Potsdam Study 35 rr\_high\_salt 1.88 Chen et al., 2018, Taiwan, Genetic Study 36 rr\_high\_sugar 1.03 Estimate from Ed Greg 37 rr\_tobacco 1.04 Andriolo et al., 2019, EPIC-Potsdam Study 38 rr\_alcohol 1.31 Pajak et al., 2013, HAPIEE Study, Russia Poland Czech 39 rr\_marital\_status\_1 1 Estimate from Ed Greg 40 rr\_marital\_status\_2 1.449 Estimate from Ed Greg 41 rr\_marital\_status\_3 1.03 Estimate from Ed Greg 42 rr\_in\_education 1 43 rr\_current\_education\_level\_1 1.34 Health Survey for England Hypertension Prevalence Models 44 rr\_current\_education\_level\_2 1 Health Survey for England Hypertension Prevalence Models 45 rr\_current\_education\_level\_3 1.42 Health Survey for England Hypertension Prevalence Models 46 rr\_unimproved\_sanitation 1 47 rr\_no\_access\_handwashing 1 48 rr\_no\_clean\_drinking\_water 1 49 rr\_wood\_burning\_stove 1 50 rr\_diabetes 1.92 Derakhshan et al., 2016, Iranian Study 51 rr\_hypertension 1 52 rr\_depression 1.42 Lin et al., 2012, Meta-Analysis Depression and Hypertension 53 rr\_chronic\_kidney\_disease 1 54 rr\_chronic\_lower\_back\_pain 1 55 rr\_chronic\_ischemic\_heart\_disease 1 56 rr\_cancers 1 57 rr\_hiv 1 58 rr\_ever\_stroke 1 59 rr\_ever\_heart\_attack 1 60 rr\_diabetes\_on\_medication 1 61 rr\_hypertension\_on\_medication 1 62 rr\_chronic\_kidney\_disease\_on\_medication 1 63 rr\_chronic\_lower\_back\_pain\_on\_medication 1 64 rr\_chronic\_ischemic\_heart\_disease\_on\_medication 1 65 rr\_stroke\_on\_medication 1 66 rr\_heart\_attack\_on\_medication 1 ==== ===================================================== =================== =========================================================== chronic_lower_back_pain ----------------------- ==== ===================================================== ================== ================================================================ .. parameter\_name value Unnamed: 2 ==== ===================================================== ================== ================================================================ 0 baseline\_annual\_probability 0.006 1 rr\_male 1 2 rr\_0\_4 0 3 rr\_5\_9 0 4 rr\_10\_14 0 5 rr\_15\_19 0 6 rr\_20\_24 0.69 7 rr\_25\_29 1 8 rr\_30\_34 1.4461538461538461 9 rr\_35\_39 2.215384615384615 10 rr\_40\_44 2.769230769230769 11 rr\_45\_49 3.538461538461538 12 rr\_50\_54 3.815384615384615 13 rr\_55\_59 5 14 rr\_60\_64 4.923076923076923 15 rr\_65\_69 4.369230769230769 16 rr\_70\_74 4.369230769230769 17 rr\_75\_79 4.923076923076923 18 rr\_80\_84 4.369230769230769 19 rr\_85\_89 3.692307692307692 20 rr\_90\_94 1.6153846153846154 21 rr\_95\_99 1.5384615384615383 22 rr\_100 1.5384615384615383 23 rr\_urban 24 rr\_wealth\_1 1 Docking et al, 2011; Cambridge City over 75s Cohort 25 rr\_wealth\_2 0.9 Docking et al, 2011; Cambridge City over 75s Cohort 26 rr\_wealth\_3 1 Docking et al, 2011; Cambridge City over 75s Cohort 27 rr\_wealth\_4 1.4 Docking et al, 2011; Cambridge City over 75s Cohort 28 rr\_wealth\_5 1.4 Docking et al, 2011; Cambridge City over 75s Cohort 29 rr\_bmi\_1 1 Heuch et al., 2013, Follow-up in the Nord-Trøndelag Health Study 30 rr\_bmi\_2 1 Heuch et al., 2013, Follow-up in the Nord-Trøndelag Health Study 31 rr\_bmi\_3 1.21 Heuch et al., 2013, Follow-up in the Nord-Trøndelag Health Study 32 rr\_bmi\_4 1.28 Heuch et al., 2013, Follow-up in the Nord-Trøndelag Health Study 33 rr\_bmi\_5 1.28 Heuch et al., 2013, Follow-up in the Nord-Trøndelag Health Study 34 rr\_low\_exercise 35 rr\_high\_salt 36 rr\_high\_sugar 37 rr\_tobacco 1.78 Shiri et al., 2010; meta-analysis 38 rr\_alcohol 39 rr\_marital\_status\_1 1 Docking et al, 2011; Cambridge City over 75s Cohort 40 rr\_marital\_status\_2 1.4285714285714286 Docking et al, 2011; Cambridge City over 75s Cohort 41 rr\_marital\_status\_3 1.5714285714285716 Docking et al, 2011; Cambridge City over 75s Cohort 42 rr\_in\_education 1.5 Docking et al, 2011; Cambridge City over 75s Cohort 43 rr\_current\_education\_level\_1 1.5 Docking et al, 2011; Cambridge City over 75s Cohort 44 rr\_current\_education\_level\_2 1 Docking et al, 2011; Cambridge City over 75s Cohort 45 rr\_current\_education\_level\_3 1 Docking et al, 2011; Cambridge City over 75s Cohort 46 rr\_unimproved\_sanitation 47 rr\_no\_access\_handwashing 48 rr\_no\_clean\_drinking\_water 49 rr\_wood\_burning\_stove 50 rr\_diabetes 2.72 Pozzobbon et al, 2019, meta-analysis 51 rr\_hypertension 0.79 Bae et al, 2015, KNHANES IV 52 rr\_depression 1.5 Docking et al, 2011; Cambridge City over 75s Cohort 53 rr\_chronic\_kidney\_disease 54 rr\_chronic\_lower\_back\_pain 55 rr\_chronic\_ischemic\_heart\_disease 56 rr\_cancers 57 rr\_hiv 1 58 rr\_ever\_stroke 2.35 Wang et al, 2020 59 rr\_ever\_heart\_attack 1 60 rr\_diabetes\_on\_medication 1 61 rr\_hypertension\_on\_medication 1 62 rr\_chronic\_kidney\_disease\_on\_medication 1 63 rr\_chronic\_lower\_back\_pain\_on\_medication 1 64 rr\_chronic\_ischemic\_heart\_disease\_on\_medication 1 65 rr\_stroke\_on\_medication 1 66 rr\_heart\_attack\_on\_medication 1 ==== ===================================================== ================== ================================================================ chronic_kidney_disease ---------------------- ==== ===================================================== ================== =========================================== .. parameter\_name value Unnamed: 2 ==== ===================================================== ================== =========================================== 0 baseline\_annual\_probability 0.0007 1 rr\_male 1.25 Judge A. et al. Nep Dial Trans. 2012 2 rr\_0\_4 0 3 rr\_5\_9 0 4 rr\_10\_14 0 5 rr\_15\_19 0 6 rr\_20\_24 0.5154639175257733 Judge A. et al. Nep Dial Trans. 2012 7 rr\_25\_29 0.5154639175257733 Judge A. et al. Nep Dial Trans. 2012 8 rr\_30\_34 0.5154639175257733 Judge A. et al. Nep Dial Trans. 2012 9 rr\_35\_39 1 Judge A. et al. Nep Dial Trans. 2012 10 rr\_40\_44 1 Judge A. et al. Nep Dial Trans. 2012 11 rr\_45\_49 1.675257731958763 Judge A. et al. Nep Dial Trans. 2012 12 rr\_50\_54 1.675257731958763 Judge A. et al. Nep Dial Trans. 2012 13 rr\_55\_59 2.8762886597938144 Judge A. et al. Nep Dial Trans. 2012 14 rr\_60\_64 2.8762886597938144 Judge A. et al. Nep Dial Trans. 2012 15 rr\_65\_69 4.190721649484536 Judge A. et al. Nep Dial Trans. 2012 16 rr\_70\_74 4.190721649484536 Judge A. et al. Nep Dial Trans. 2012 17 rr\_75\_79 5.190721649484536 Judge A. et al. Nep Dial Trans. 2012 18 rr\_80\_84 5.190721649484536 Judge A. et al. Nep Dial Trans. 2012 19 rr\_85\_89 2.0876288659793816 Judge A. et al. Nep Dial Trans. 2012 20 rr\_90\_94 2.0876288659793816 Judge A. et al. Nep Dial Trans. 2012 21 rr\_95\_99 2.0876288659793816 Judge A. et al. Nep Dial Trans. 2012 22 rr\_100 2.0876288659793816 Judge A. et al. Nep Dial Trans. 2012 23 rr\_urban 24 rr\_wealth\_1 1 Weldegiorgis M. et al. Nep Dial Trans. 2020 25 rr\_wealth\_2 1.26 Weldegiorgis M. et al. Nep Dial Trans. 2020 26 rr\_wealth\_3 1.36 Weldegiorgis M. et al. Nep Dial Trans. 2020 27 rr\_wealth\_4 1.63 Weldegiorgis M. et al. Nep Dial Trans. 2020 28 rr\_wealth\_5 1.73 Weldegiorgis M. et al. Nep Dial Trans. 2020 29 rr\_bmi\_1 1.02 Herrington WG. et al. PLoS One. 2017 30 rr\_bmi\_2 1 Herrington WG. et al. PLoS One. 2018 31 rr\_bmi\_3 1.45 Herrington WG. et al. PLoS One. 2019 32 rr\_bmi\_4 1.66 Herrington WG. et al. PLoS One. 2020 33 rr\_bmi\_5 2.2 Herrington WG. et al. PLoS One. 2021 34 rr\_low\_exercise 35 rr\_high\_salt 36 rr\_high\_sugar 37 rr\_tobacco 1.24 Bello A et al. Clin J Am Soc Nephrol. 2008 38 rr\_alcohol 1.33 Hossain M et al. Nephron Clin Pract. 2012 39 rr\_marital\_status\_1 1 Akrawi D et al. Eur J Intern Med. 2014 40 rr\_marital\_status\_2 0.8620689655172414 Akrawi D et al. Eur J Intern Med. 2014 41 rr\_marital\_status\_3 0.8620689655172414 Akrawi D et al. Eur J Intern Med. 2014 42 rr\_in\_education 1.3454545454545452 Weldegiorgis M. et al. Nep Dial Trans. 2020 43 rr\_current\_education\_level\_1 1.1818181818181817 Fored C et al. Nep Dial Tran. 2003 44 rr\_current\_education\_level\_2 1 Fored C et al. Nep Dial Tran. 2003 45 rr\_current\_education\_level\_3 0.9090909090909091 Fored C et al. Nep Dial Tran. 2003 46 rr\_unimproved\_sanitation 47 rr\_no\_access\_handwashing 48 rr\_no\_clean\_drinking\_water 49 rr\_wood\_burning\_stove 50 rr\_diabetes 1.87 Bello A et al. Clin J Am Soc Nephrol. 2008 51 rr\_hypertension 1.75 Bello A et al. Clin J Am Soc Nephrol. 2008 52 rr\_depression 1.62 Kop W et al. Clin J Am Soc Nephrol. 2011 53 rr\_chronic\_kidney\_disease 1 54 rr\_chronic\_lower\_back\_pain 1.3 Lipworth et al. PlosOne 2012 55 rr\_chronic\_ischemic\_heart\_disease 1 56 rr\_cancers 1 57 rr\_hiv 1 58 rr\_ever\_stroke 1 59 rr\_ever\_heart\_attack 1 60 rr\_diabetes\_on\_medication 1 61 rr\_hypertension\_on\_medication 1 62 rr\_chronic\_kidney\_disease\_on\_medication 1 63 rr\_chronic\_lower\_back\_pain\_on\_medication 1 64 rr\_chronic\_ischemic\_heart\_disease\_on\_medication 1 65 rr\_stroke\_on\_medication 1 66 rr\_heart\_attack\_on\_medication 1 ==== ===================================================== ================== =========================================== chronic_ischemic_hd ------------------- ==== ===================================================== ================== ==================================================================================================================================================================================================================================================== .. parameter\_name value Unnamed: 2 ==== ===================================================== ================== ==================================================================================================================================================================================================================================================== 0 baseline\_annual\_probability 8.6e-05 1 rr\_male 2.3 2 rr\_0\_4 0 3 rr\_5\_9 0 4 rr\_10\_14 0 5 rr\_15\_19 0 6 rr\_20\_24 0.1401360544217687 IHME https://vizhub.healthdata.org/gbd-compare/ 7 rr\_25\_29 1 IHME https://vizhub.healthdata.org/gbd-compare/ 8 rr\_30\_34 1 IHME https://vizhub.healthdata.org/gbd-compare/ 9 rr\_35\_39 1 IHME https://vizhub.healthdata.org/gbd-compare/ 10 rr\_40\_44 1 IHME https://vizhub.healthdata.org/gbd-compare/ 11 rr\_45\_49 1 IHME https://vizhub.healthdata.org/gbd-compare/ 12 rr\_50\_54 7 IHME https://vizhub.healthdata.org/gbd-compare/ 13 rr\_55\_59 7 IHME https://vizhub.healthdata.org/gbd-compare/ 14 rr\_60\_64 7 IHME https://vizhub.healthdata.org/gbd-compare/ 15 rr\_65\_69 7 IHME https://vizhub.healthdata.org/gbd-compare/ 16 rr\_70\_74 12 IHME https://vizhub.healthdata.org/gbd-compare/ 17 rr\_75\_79 12 IHME https://vizhub.healthdata.org/gbd-compare/ 18 rr\_80\_84 12 IHME https://vizhub.healthdata.org/gbd-compare/ 19 rr\_85\_89 12 IHME https://vizhub.healthdata.org/gbd-compare/ 20 rr\_90\_94 12 IHME https://vizhub.healthdata.org/gbd-compare/ 21 rr\_95\_99 12 IHME https://vizhub.healthdata.org/gbd-compare/ 22 rr\_100 12 IHME https://vizhub.healthdata.org/gbd-compare/ 23 rr\_urban 24 rr\_wealth\_1 1 Witte et al., 2017, Deprivation Chronic Heart Failure, UK 25 rr\_wealth\_2 1.12 Witte et al., 2017, Deprivation Chronic Heart Failure, UK 26 rr\_wealth\_3 1.24 Witte et al., 2017, Deprivation Chronic Heart Failure, UK 27 rr\_wealth\_4 1.36 Witte et al., 2017, Deprivation Chronic Heart Failure, UK 28 rr\_wealth\_5 1.48 Witte et al., 2017, Deprivation Chronic Heart Failure, UK 29 rr\_bmi\_1 1 Jousilahti et al, 1996, BMI CVD Finland 30 rr\_bmi\_2 1 Jousilahti et al, 1996, BMI CVD Finland 31 rr\_bmi\_3 2.08 Jousilahti et al, 1996, BMI CVD Finland 32 rr\_bmi\_4 7.28 Jousilahti et al, 1996, BMI CVD Finland 33 rr\_bmi\_5 12.48 Jousilahti et al, 1996, BMI CVD Finland 34 rr\_low\_exercise 2.4 Strazzullo et al, 2009, Meta-analysis 35 rr\_high\_salt 1.17 Strazzullo et al, 2009, Meta-analysis 36 rr\_high\_sugar 37 rr\_tobacco 1.4 Strazzullo et al, 2009, Meta-analysis 38 rr\_alcohol 1.44 Emberson et al., 2005 Alcohol CHD 39 rr\_marital\_status\_1 40 rr\_marital\_status\_2 41 rr\_marital\_status\_3 42 rr\_in\_education 1.67 Kilander et al, 2001, Swedish Cohort Men 43 rr\_current\_education\_level\_1 1.67 Kilander et al, 2001, Swedish Cohort Men 44 rr\_current\_education\_level\_2 1 45 rr\_current\_education\_level\_3 1 46 rr\_unimproved\_sanitation 47 rr\_no\_access\_handwashing 48 rr\_no\_clean\_drinking\_water 49 rr\_wood\_burning\_stove 50 rr\_diabetes 2.19 Asia Pacific Cohort Studies Collaboration, 2003 51 rr\_hypertension 3.8 Alderman et al, 1997, MI HTN 52 rr\_depression 53 rr\_chronic\_kidney\_disease 1.55 Angelantonio et al., 2010, Prospective Study Iceland 54 rr\_chronic\_lower\_back\_pain 55 rr\_chronic\_ischemic\_heart\_disease 56 rr\_cancers 57 rr\_hiv 1.61 58 rr\_ever\_stroke 1 59 rr\_ever\_heart\_attack 1 60 rr\_diabetes\_on\_medication 1 61 rr\_hypertension\_on\_medication 0.72 Neal et al., Effects of ACE inhibitors, calcium antagonists, and other blood- pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration, The Lancet 2000 62 rr\_chronic\_kidney\_disease\_on\_medication 1 63 rr\_chronic\_lower\_back\_pain\_on\_medication 1 64 rr\_chronic\_ischemic\_heart\_disease\_on\_medication 1 65 rr\_stroke\_on\_medication 1 66 rr\_heart\_attack\_on\_medication 1 ==== ===================================================== ================== ====================================================================================================================================================================================================================================================